ACTIVE

IMMOBILIERE PRIMA

Financial year 2025 · Closed on 31/12/2025

Net result12,7 k €+104,4 %over 1 year
Gross margin46,1 k €+118,0 %over 1 year
Equity1,1 M €+1,2 %over 1 year

Identity

Source · BCE/KBO

IMMOBILIERE PRIMA is a Public limited company incorporated in 1999. Its main activity is: Real estate agencies. Its registered office is in Frameries.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0466.956.812
Incorporation
30/09/1999
Legal form
Public limited company
Registered office
Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital
1 239 468,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin46,1 k €-255,9 k €22,8 k €42,4 k €54,3 k €
EBITDA43,9 k €-258,1 k €20,8 k €3,9 k €52,5 k €
Operating result13,6 k €-288,2 k €-9,3 k €-25,9 k €22,9 k €
Net result12,7 k €-289 k €-35,1 k €-4,3 k €16,6 k €
Balance sheet
Equity1,1 M €1,1 M €1,4 M €1,4 M €1,4 M €
Total assets1,3 M €1,3 M €1,5 M €1,6 M €1,7 M €
Cash430,2 k €376,9 k €305,5 k €324,7 k €315 k €
Debts157,3 k €157,1 k €154,8 k €156,2 k €256 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

GESTIPHARMA

Managing director · since 23 mai 2022 · until 22 mai 2028 · 0425.530.684

Represented by Pierre-Pascal HECQ

Active
WINGS FARMA

Director · since 23 mai 2022 · until 22 mai 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Active

Ended mandates

WINGS FARMA

Director · since 23 mai 2022 · until 24 juin 2024 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Ended
GESTIPHARMA

Managing director · since 25 juin 2018 · until 24 juin 2024 · 0425.530.684

Represented by Pierre-Pascal HECQ

Ended
UNIVERSAL PHARMA

Director · since 25 juin 2018 · until 23 mai 2022 · 0447.382.113

Ended
UNIVERSAL PHARMA

Director · since 25 juin 2018 · until 24 juin 2024 · 0447.382.113

Represented by PIERRE-PASCAL HECQ

Ended

Other companies at this address

Rue Montavaux 155 7080 Frameries
CompanyCBE no.
ASSCOT● Active
0447.778.625
0478.169.913
BEPHAR● Active
0450.260.538
EVRAS● Active
0417.723.174
FARMIMMO● Active
0429.198.175
FELIX PHARMA● Active
0477.939.091
0443.155.782
0403.358.761
0435.700.442
0403.082.213
OBIPHAR● Active
0878.100.418
0882.318.631
0423.162.203
0867.368.654
0842.900.009
0479.179.208
0419.745.130
0447.088.737
0439.400.397
PHARMANET● Active
0426.485.640

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202614/07/202506/08/202423/08/202318/08/202209/08/2021
General meeting22/06/202623/06/202524/06/202426/06/202327/06/202228/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202522/06/202630/06/2026FrenchPDF
Micro model31/12/202423/06/202514/07/2025FrenchPDF
Micro model31/12/202324/06/202406/08/2024FrenchPDF
Micro model31/12/202226/06/202323/08/2023FrenchPDF
Micro model31/12/202127/06/202218/08/2022FrenchPDF
Abridged model31/12/202028/06/202109/08/2021FrenchPDF
Abridged model31/12/201922/06/202025/08/2020FrenchPDF
Abridged model31/12/201824/06/201907/08/2019FrenchPDF
Abridged model31/12/201725/06/201820/07/2018FrenchPDF
Abridged model31/12/201626/06/201703/07/2017FrenchPDF
Abridged model31/12/201527/06/201619/07/2016FrenchPDF
Abridged model31/12/201422/06/201514/08/2015FrenchPDF
Abridged model31/12/201323/06/201407/08/2014FrenchPDF
Abridged model31/12/201224/06/201325/06/2013FrenchPDF
Abridged model31/12/201125/06/201209/07/2012FrenchPDF
Abridged model31/12/201020/06/201129/07/2011FrenchPDF
Abridged model31/12/200921/06/201029/06/2010FrenchPDF
Abridged model31/12/200822/06/200923/07/2009FrenchPDF
Abridged model31/12/200723/06/200801/08/2008FrenchPDF
Abridged model31/12/200625/06/200720/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

GESTIPHARMA

Managing director · since 23 mai 2022 · until 22 mai 2028 · 0425.530.684

Represented by Pierre-Pascal HECQ

Active
WINGS FARMA

Director · since 23 mai 2022 · until 22 mai 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Active

Ended mandates

WINGS FARMA

Director · since 23 mai 2022 · until 24 juin 2024 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Ended
GESTIPHARMA

Managing director · since 25 juin 2018 · until 24 juin 2024 · 0425.530.684

Represented by Pierre-Pascal HECQ

Ended
UNIVERSAL PHARMA

Director · since 25 juin 2018 · until 23 mai 2022 · 0447.382.113

Ended
UNIVERSAL PHARMA

Director · since 25 juin 2018 · until 24 juin 2024 · 0447.382.113

Represented by PIERRE-PASCAL HECQ

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/06/2022
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates19/03/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Other27/12/2013
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates10/07/2013
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares21/02/2012
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates28/11/2006
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202512,7 k €↑
  2. 2024
    Annual accounts 2024-289 k €↓
  3. 2023
    Annual accounts 2023-35,1 k €↓
  4. 2022
    Annual accounts 2022-4,3 k €↓
  5. 2021
    Annual accounts 202116,6 k €↓
  6. 2020
    Annual accounts 202093 k €↑
  7. 2019
    Annual accounts 2019-2,3 k €↑
  8. 2018
    Annual accounts 2018-15,8 k €↓
  9. 2017
    Annual accounts 201724,2 k €↑
  10. 2016
    Annual accounts 20164,1 k €↓
  11. 2015
    Annual accounts 201545,5 k €↓
  12. 2014
    Annual accounts 201459,8 k €↑
  13. 2013
    Annual accounts 201316,9 k €↓
  14. 2012
    Annual accounts 2012163,8 k €↑
  15. 2011
    Annual accounts 20119,5 k €↑
  16. 2010
    Annual accounts 20102,2 k €↓
  17. 2009
    Annual accounts 200962,5 k €↓
  18. 2008
    Annual accounts 2008108,5 k €↑
  19. 2007
    Annual accounts 200751,7 k €↑
  20. 2006
    Annual accounts 200638,4 k €
  21. 30/09/1999
    IncorporationPublic limited company